Advertisement
Screener

BioCorRx Inc. (BICX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

2.8 / 5 stars · 68/120 Roast Me

BioCorRx Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

BioCorRx Inc. (BICX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 349.06 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-03-31

  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-12-31 was 106.54K shares, a 72.18% decline year-over-year.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 79.48K shares, a 19.26% decline year-over-year.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-06-30 was 89.15K shares, a 38.68% increase year-over-year.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-03-31 was 73.89K shares, a 26.03% increase year-over-year.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 349.06K shares, a 42.23% decline from fiscal 2024.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 604.24K shares, a 2249.41% increase from fiscal 2023.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 25.72K shares, a 56.45% decline from fiscal 2022.
  • BioCorRx Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 59.06K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 1 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed
2025-12-31106.54K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
186.02K shares
derived: sum of 2 quarters · filed 2026-03-31
275.17K shares
derived: sum of 3 quarters · filed 2026-03-31
349.06K shares
10-K · filed 2026-03-31
2025-09-3079.48K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
168.63K shares
derived: sum of 2 quarters · filed 2025-11-14
242.52K shares
10-Q · filed 2025-11-14
625.41K shares
derived: sum of 4 quarters · filed 2026-03-31
2025-06-3089.15K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
163.04K shares
10-Q · filed 2025-08-14
545.93K shares
derived: sum of 3 quarters · filed 2026-03-31
644.37K shares
derived: sum of 4 quarters · filed 2026-03-31
2025-03-3173.89K shares
10-Q · filed 2025-05-15
456.78K shares
derived: sum of 2 quarters · filed 2026-03-31
555.22K shares
derived: sum of 3 quarters · filed 2026-03-31
619.50K shares
derived: sum of 4 quarters · filed 2026-03-31
2024-12-31382.89K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
481.33K shares
derived: sum of 2 quarters · filed 2026-03-31
545.62K shares
derived: sum of 3 quarters · filed 2026-03-31
604.24K shares
10-K · filed 2026-03-31
2024-09-3098.44K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
162.72K shares
derived: sum of 2 quarters · filed 2024-11-14
221.35K shares
10-Q · filed 2024-11-14
221.35K shares
derived: sum of 4 quarters · filed 2025-03-31
2024-06-3064.29K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
122.91K shares
10-Q · filed 2024-08-13
122.91K shares
derived: sum of 3 quarters · filed 2025-03-31
131.49K shares
derived: sum of 4 quarters · filed 2025-03-31
2024-03-3158.63K shares
10-Q · filed 2024-05-15
58.63K shares
derived: sum of 2 quarters · filed 2025-03-31
67.20K shares
derived: sum of 3 quarters · filed 2025-03-31
75.87K shares
derived: sum of 4 quarters · filed 2025-03-31
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
8.57K shares
derived: sum of 2 quarters · filed 2025-03-31
17.25K shares
derived: sum of 3 quarters · filed 2025-03-31
25.72K shares
10-K · filed 2025-03-31
2023-09-308.57K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
17.25K shares
derived: sum of 2 quarters · filed 2023-11-14
25.72K shares
10-Q · filed 2023-11-14
41.68K shares
derived: sum of 4 quarters · filed 2024-04-01
2023-06-308.67K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
17.14K shares
10-Q · filed 2023-08-14
33.10K shares
derived: sum of 3 quarters · filed 2024-04-01
48.20K shares
derived: sum of 4 quarters · filed 2024-04-01
2023-03-318.47K shares
10-Q · filed 2023-05-15
24.43K shares
derived: sum of 2 quarters · filed 2024-04-01
39.53K shares
derived: sum of 3 quarters · filed 2024-04-01
50.80K shares
derived: sum of 4 quarters · filed 2024-04-01
2022-12-3115.96K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
31.05K shares
derived: sum of 2 quarters · filed 2024-04-01
42.33K shares
derived: sum of 3 quarters · filed 2024-04-01
59.06K shares
10-K · filed 2024-04-01
2022-09-3015.10K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
26.37K shares
derived: sum of 2 quarters · filed 2022-11-14
43.10K shares
10-Q · filed 2022-11-14
2022-06-3011.28K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
28.00K shares
10-Q · filed 2022-08-15
2022-03-3116.73K shares
10-Q · filed 2022-05-16
2022-02-28229.89K shares
10-K · filed 2022-03-31
2021-12-310.00 shares
10-K · filed 2022-03-31
2020-12-317.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
15.83K shares
10-K · filed 2022-03-31
2020-09-308.33K shares
10-Q · filed 2020-11-16
2019-12-3153.28K shares
10-K · filed 2021-03-31
2019-06-3053.28K shares
10-Q · filed 2019-08-14
2018-12-31315.00K shares
10-K · filed 2020-03-30
2018-06-30-31.50M shares
10-Q · filed 2018-08-14
2017-12-31-34.65K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16
350.00 shares
10-K · filed 2019-04-16
35.00K shares
10-K · filed 2018-04-05
2017-09-3035.00K shares
10-Q · filed 2017-11-14
2016-12-3133.00M shares
10-K · filed 2018-04-05
2015-12-314.50M shares
10-K · filed 2017-04-13
2014-12-311.48M shares
10-Q · filed 2015-11-16